Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Terni – page 7

95 clinical trials in Terni, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Terni at a glance
95
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

95 trials in Terni

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dextrose Bp
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Ceska Myelomova Skupina z.s.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Idelalisib
  • Sponsor:Loxo Oncology Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Seagen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Chlorambucil
  • Sponsor:F. Hoffmann-La Roche AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Terni

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking trials focusing on blood-based cancers, including studies of novel therapeutic combinations for chronic lymphocytic leukemia and multiple myeloma. Research explores innovative treatment approaches using targeted therapies and immunotherapy.

  • Follicular Lymphoma Studies
  • Chronic Myeloid Leukemia Research
  • Multiple Myeloma Treatments

Investigations include maintenance therapies and combination approaches with drugs like venetoclax and obinutuzumab.

02 Solid Tumor Research

Advanced clinical trials targeting various solid tumors, with particular focus on prostate cancer and breast cancer. Studies evaluate novel drug combinations and immunotherapy approaches.

  • Metastatic Prostate Cancer
  • Triple-Negative Breast Cancer
  • Advanced Renal Cell Carcinoma

Research emphasizes personalized treatment strategies and targeted therapeutic approaches.

03 Lung Cancer Innovation

Cutting-edge research in non-small cell lung cancer treatment, investigating novel combinations of immunotherapy and targeted agents. Studies focus on improving outcomes for patients with advanced disease.

  • EGFR-Mutated NSCLC
  • Immunotherapy Combinations
  • Advanced Disease Management

Trials explore innovative treatment sequences and combination approaches for better patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.